In tumor cells, an increased uptake of F18-FDG is seen; this can be explained by overexpression of the GLUT isotypes—mostly GLUT-1, GLUT-3, and GLUT-5- and overproduction of glycolytic enzymes. This evidence concerns the gene SLC2A1 and neoplasm.